GammaDelta Therapeutics Limited is a UK headquartered biotechnology. The company was founded on the basis of world-class academic research conducted at King’s College London and the Francis Crick Institute.
GammaDelta Therapeutics aims to harness the unique properties of a subset of γδ T cells to improve patient outcomes and survival rates among patients with certain haematological malignancies and solid tumours.
Douglass Digital was approached by GammaDelta Therapeutics to provide a brand new website that was more dynamic, simpler to update, manage and with an enhanced visual appearance.